Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 14, 2024 |
| Target | Longboard Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | H. Lundbeck |
| Sellers(s) | HBM Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.6B USD |
| Advisor(s) | Evercore Group Centerview Partners (Financial) Cooley (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1915 |
| Sector | Healthcare Services |
| Employees | 5,700 |
| Revenue | 22.0B DKK (2024) |
H. Lundbeck is an international pharmaceutical company engaged inthe research and development, production, marketing and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. H. Lundbeck was founded in 1915 and is based in Valby, Denmark.
| Deal Context for Buyer | # |
|---|---|
| Overall | 6 of 6 |
| Sector: Life Science | 6 of 6 |
| Type: Add-on Acquisition | 5 of 5 |
| State: California | 2 of 2 |
| Country: United States | 5 of 5 |
| Year: 2024 | 1 of 1 |
| Size (of disclosed) | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-09-16 |
Alder Biopharmaceuticals
Bothell, Washington, United States Alder Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel antibodies that originate from its proprietary platform for the production of antibodies in picchia. Alder Biopharmaceuticals was formed in 2002 and is based in Bothell, Washington. |
Buy | $2.0B |
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| Deal Context for Seller | # |
|---|---|
| Overall | 36 of 40 |
| Sector: Life Science | 32 of 35 |
| Type: Add-on Acquisition | 6 of 7 |
| State: California | 9 of 9 |
| Country: United States | 27 of 27 |
| Year: 2024 | 3 of 4 |
| Size (of disclosed) | 3 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-10-14 |
Gynesonics
Redwood City, California, United States Gynesonics is a medical device company, develops minimally invasive therapeutic device to treat uterine fibroids in women. Gynesonics was founded in 2005 and is based in Redwood City, California. |
Sell | $350M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-18 |
Sai Life
Hyderabad, India Sai Life is an integrated provider of drug discovery, development, and manufacturing solutions for innovator pharmaceutical and biotechnology companies. The company’s ongoing commitment to quality, thorough approach, and state-of-the-art research and manufacturing facilities enable its highly skilled team of professionals to provide its clients with competitive advantages such as shorter time to market and risk minimization. Sai Life was founded in 1999 and is based in Hyderabad, Telangana. |
Sell | - |
